Calcium 2-ethylhexanoate and 2-ethylhexyl-2-ethylhexanoate
Information Sheet
These substances were identified for action under the Chemicals Management Plan (CMP).
CAS RN | Common name | DSL name | Proposed Order and RIAS | Final screening assessment | Proposed risk management approach | Conclusion on section 64 criteria | Follow-up activities |
---|---|---|---|---|---|---|---|
136-51-6 | Calcium 2-ethylhexanoate | Hexanoic acid, 2-ethyl-, calcium salt | N/A | HTML | N/A | Does not meet | Significant New Activity (SNAc) provisions |
7425-14-1 | 2-Ethylhexyl-2-ethylhexanoate | Hexanoic acid, 2-ethyl-, 2-ethylhexyl ester | HTML | HTML | Meets one or more of the criteria | Refer to proposed risk management approach |
Follow-up activities
While calcium 2-ethylhexanoate is not considered to be harmful to human health at levels of exposure considered in the assessment, it is considered to have a health effect of concern due to its potential developmental toxicity. Therefore, there may be a potential concern if exposures were to increase. The proposed follow-up activity for calcium 2-ethylhexanoate is to apply the SNAc provisions of the Canadian Environmental Protection Act, 1999 (CEPA 1999).
Date | Activity |
---|---|
September 12, 2020 | Publication in the Canada Gazette, Part I: Vol. 15, No. 37 of the notice of intent to amend the Domestic Substances List (DSL) to apply the SNAc provisions of CEPA 1999 to 2-ethylhexyl-2-ethylhexanoate and start of 60-day public comment period. |
March 2, 2019 | Publication of a proposed order adding 2-ethylhexyl-2-ethylhexanoate to Schedule 1 of CEPA 1999. The related notice was published in the Canada Gazette, Part I: Vol. 153, No. 9. |
December 15, 2018 | Publication of the Final Screening Assessment for Calcium 2-Ethylhexanoate and 2-Ethylhexyl-2-ethylhexanoate, and the Risk Management Approach for 2-Ethylhexyl-2-ethylhexanoate. The related notice was published in the Canada Gazette, Part I: Vol. 152, No. 50. |
December 15, 2018 | Publication in the Canada Gazette, Part I: Vol. 152, No. 50 of the notice of intent to amend the DSAL to apply the SNAc provisions of CEPA 1999 to calcium 2-ethylhexanoateand start of 60-day public comment period. |
March 25, 2017 | Publication and start of 60-day public comment period on the Draft Screening Assessment for Calcium 2-Ethylhexanoate and 2-Ethylhexyl-2-ethylhexanoate (including follow-up activities for calcium 2-ethylhexanoate) and the Risk Management Scope for 2-Ethylhexyl-2-ethylhexanoate. The related notice was published in the Canada Gazette, Part I: Vol. 151, No. 12. |
Report a problem or mistake on this page
- Date modified: